Skip to content

Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty

A Prospective, Non-Randomized, Limited-Use Evaluation of the ENTact Septal Staple System for Tissue Approximation During Septoplasties

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00740480
Enrollment
25
Registered
2008-08-25
Start date
2008-04-30
Completion date
2009-02-28
Last updated
2009-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Septum

Keywords

Evaluation, ENTact™, Septal, Staple, System, tissue, approximation, during, septoplasties

Brief summary

The purpose of this research study is to learn more about the ENTact™ Septal Staple System device performance and to collect information to support its premarket application.

Detailed description

The ENTact™ Staple System is a device that inserts a small staple or tack to hold mucosa (moist tissues) in place instead of using stitches. The staple gradually dissolves and does not need to be removed. This clinical study will evaluate: * surgical performance of the ENTact Septal Staple System * one week post op clinical evaluation of gross tissue appearance at implantation site(s) * ENTact™ Septal Staple functionality based on maintained coaptation

Interventions

None listed

Sponsors

ENTrigue Surgical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult patients, between the ages of 18 and 65 years, with a clinically significant deviation of the nasal septum * Patient is able to provide a signed informed consent form * Patient will agree to comply with all study related procedures * Patient is not pregnant at this time. If patient is of child-bearing age and capable of bearing children, a pre-operative pregnancy test confirmation is required to show that patient is not pregnant on the day of surgery * Patient does not plan on becoming pregnant and is not breast feeding during the course of the study

Exclusion criteria

* Patients who do not meet the inclusion criteria * Patients who have had previous septoplasty * Patients with uncontrolled diabetes * Presence of infection at the site * Smokers and severe drug and alcohol abusers * Patients with autoimmune disease deemed clinically significant by Principal Investigator

Design outcomes

Primary

MeasureTime frameDescription
Coaptation (Tissue Approximation)One week post surgeryComplete tissue approximation at one week.

Secondary

MeasureTime frameDescription
Tissue Reaction to ImplantOne week post surgeryNone - no edema, erythema or purulence around the area of the staples Mild - slight erythema and/or edema in the region of one or more staple, limited to not greater than 2 mm from the staple Moderate - erythema and/or edema in the region of one or more staples, greater than 2 mm extension from the staples Severe - Generalized edema and/or erythema of the septum, or purulence and/or granulation tissue involved in one or more staples.

Countries

United States

Participant flow

Recruitment details

Chart reviews and patient contact in clinic. Recruitment period from July 2008 to January 2009.

Participants by arm

ArmCount
Septal Stapler Group
Adult population (ages 18-65) with clinically significant nasal septum deviation.
25
Total25

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall StudyPhysician Decision1

Baseline characteristics

CharacteristicSeptal Stapler Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
25 Participants
Age Continuous39.9 years
STANDARD_DEVIATION 13.7
Region of Enrollment
United States
25 participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
12 Participants

Outcome results

Primary

Coaptation (Tissue Approximation)

Complete tissue approximation at one week.

Time frame: One week post surgery

Population: ITT

ArmMeasureValue (NUMBER)
Septal Stapler GroupCoaptation (Tissue Approximation)23 participants
Secondary

Tissue Reaction to Implant

None - no edema, erythema or purulence around the area of the staples Mild - slight erythema and/or edema in the region of one or more staple, limited to not greater than 2 mm from the staple Moderate - erythema and/or edema in the region of one or more staples, greater than 2 mm extension from the staples Severe - Generalized edema and/or erythema of the septum, or purulence and/or granulation tissue involved in one or more staples.

Time frame: One week post surgery

Population: ITT

ArmMeasureGroupValue (NUMBER)
Septal Stapler GroupTissue Reaction to ImplantNo reaction18 participants
Septal Stapler GroupTissue Reaction to ImplantMild reaction5 participants
Septal Stapler GroupTissue Reaction to ImplantModerate reaction0 participants
Septal Stapler GroupTissue Reaction to ImplantSevere reaction0 participants
Septal Stapler GroupTissue Reaction to ImplantCannot assess2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026